Treatment of HER2-Expressing Breast Cancer and Ovarian Cancer Cells With Alpha Particle-Emitting 227Th-Trastuzumab-Reference-Cited by-同舟云学术

Treatment of HER2-Expressing Breast Cancer and Ovarian Cancer Cells With Alpha Particle-Emitting 227Th-Trastuzumab

Published:2011-02 Issue:2 Volume:79 Page:563-570
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Heyerdahl Helen,Krogh Cecilie,Borrebæk Jørgen,Larsen Åsmund,Dahle Jostein

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference14 articles.

1. Pharmacokinetics and dosimetry of an alpha particle emitter labeled antibody: 213Bi-HuM195 (anti-CD33) in patients with leukemia;Sgouros;J Nucl Med,1999

2. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987

3. Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites;Gancberg;Ann Oncol,2002

4. Evaluation of monoclonal humanized anti-HER2 antibody, trastuzumab, in patients with recurrent or refractory ovarian or primary peritoneal carcinoma with overexpression of HER2: A phase II trial of the Gynecologic Oncology Group;Bookman;J Clin Oncol,2003

5. In vitro cytotoxicity of (211)At-labeled trastuzumab in human breast cancer cell lines: Effect of specific activity and HER2 receptor heterogeneity on survival fraction;Akabani;Nucl Med Biol,2006

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical Efficacy of a PSMA-Targeted Actinium-225 Conjugate (225Ac-Macropa-Pelgifatamab): A Targeted Alpha Therapy for Prostate Cancer;Clinical Cancer Research;2024-04-09

2. Mono- and multimeric PSMA-targeting small molecule-thorium-227 conjugates for optimized efficacy and biodistribution in preclinical models;European Journal of Nuclear Medicine and Molecular Imaging;2023-10-26

3. Alpha‐emitters and targeted alpha therapy in cancer treatment;iRADIOLOGY;2023-08-22

4. Targeted thorium-227 conjugates as treatment options in oncology;Frontiers in Medicine;2023-01-09

5. Development of radiopharmaceuticals for targeted alpha therapy: Where do we stand?;Frontiers in Medicine;2022-12-22